“…Other potential roadblocks, such as the needs for good manufacturing practices, licenses for serum preparation, protocol optimization and standardization, and cost and inconvenience to patients were discussed by Ralph and colleagues 25 . One case report 33 detailed the use of allogeneic serum albumin donated from close relatives as an option for kcs treatment.…”